Dr. Alfano will help the company radically redefine the care model for cancer survivorship.
CAMBRIDGE, MA / ACCESS Newswire / July 22, 2025 / OncoveryCare, which delivers virtual, whole-person care to cancer survivors, today announced that Catherine M. Alfano, PhD, has joined as Chief Product & Strategy Officer. Dr. Alfano, a renowned expert in cancer survivorship, brings a wealth of experience in clinical innovation and research. In her new role, she will help evolve OncoveryCare's novel survivorship model and scale it across the oncology ecosystem.
"I am thrilled at the opportunity to join this dream team to optimize and scale this next-generation model of chronic care for cancer survivors. Together, we can deliver personalized care to meet the needs of the growing number of survivors, streamline busy oncology clinics, and address critical workforce shortages," said Dr. Alfano.
Dr. Alfano is an internationally recognized leader in cancer survivorship. Before joining OncoveryCare, she served as Vice President of Cancer Care Management and Research at the Northwell Health Cancer Institute, driving care innovation. She previously served as Vice President of Survivorship at the American Cancer Society, where she led research, programming, and policy efforts to improve outcomes for cancer survivors nationwide. Before that, she served as Deputy Director of the National Cancer Institute's Office of Cancer Survivorship.
She has collaborated with the American Society of Clinical Oncology (ASCO) on national efforts to develop risk-stratified survivorship care models. Dr. Alfano has held several national leadership roles, including Chair of the Cancer Special Interest Group for the Society of Behavioral Medicine and Co-Chair of the ASCO Clinical Practice Guideline Panel on diet, physical activity, and weight management during cancer treatment.
A prolific researcher, Dr. Alfano has authored over 180 peer-reviewed articles and led numerous studies focusing on the chronic and late effects of cancer, cancer rehabilitation, and digital tools to support survivor health.
Dr. Justin Grischkan, Co-Founder and Chief Medical Officer, said, "Dr. Alfano is internationally-recognized for her contributions to the field of cancer survivorship. Her addition to the OncoveryCare team reflects her unwavering commitment to expanding survivorship care nationwide."
Hil Moss, Co-Founder and CEO, said, "Dr. Alfano has long been an innovative force in the survivorship community. She will be instrumental in advancing our mission to transform care for cancer survivors. We could not be more thrilled to have her join our executive team."
Dr. Alfano joins OncoveryCare in a moment of rapid growth for the company as it scales a novel survivorship model following a $4.5M seed round in 2024.
About OncoveryCare
OncoveryCare delivers comprehensive, whole-person care to cancer survivors. As the population of survivors grows rapidly alongside advances in medicine, OncoveryCare provides the personalized, longitudinal care that cancer survivors need to lead happier, healthier lives. Founded by a breast cancer survivor and a physician, OncoveryCare deploys a survivorship-trained clinical team to treat the chronic and late-effects of each survivor's cancer treatment and equip survivors with the tools they need to manage their survivorship journey.
OncoveryCare is backed by leading investors and oncology stakeholders, including .406 Ventures, Tennessee Oncology's McKay Institute, F-Prime, and Oncology Ventures. Learn more at www.oncoverycare.com, and follow us on LinkedIn and Instagram @oncoverycare.
Marketing Contact
Chloe Baldwin
Senior Manager, Community & Marketing
chloe@oncoverycare.com
SOURCE: OncoveryCare
View the original press release on ACCESS Newswire